Reduced Neointima Formation After Arterial Injury in CD4-/- Mice Is Mediated by CD8+CD28hi T Cells

Journal of the American Heart Association - United Kingdom
doi 10.1161/jaha.113.000155
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Neointimal Formation Is Reduced After Arterial Injury in Human CRP Transgenic Mice

Atherosclerosis
Cardiovascular MedicineCardiology
2008English

CD8 T Cells Modulate CD4 T-Cell and Eosinophil-Mediated Pulmonary Pathology in Pneumocystis Pneumonia in B-Cell-Deficient Mice

American Journal of Pathology
Forensic MedicinePathology
2006English

CD8+ T Cells Control the TH Phenotype of MBP-reactive CD4+ T Cells in EAE Mice

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

CD4+CD25+ Regulatory T Cells Suppress Allograft Rejection Mediated by Memory CD8+ T Cells via a CD30-dependent Mechanism

Journal of Clinical Investigation
Medicine
2004English

The CD8 Population in CD4-deficient Mice Is Heavily Contaminated With MHC Class II–restricted T Cells

Journal of Experimental Medicine
MedicineAllergyImmunology
2004English

Virus-Induced Delayed-Type Hypersensitivity Reaction Is Sequentially Mediated by CD8+ and CD4+ T Lymphocytes.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1989English

Plasminogen Activator Inhibitor Type 1 Enhances Neointima Formation After Oxidative Vascular Injury in Atherosclerosis-Prone Mice

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

CD8 T Cell-Mediated Killing of Cryptococcus Neoformans Requires Granulysin and Is Dependent on CD4 T Cells and IL-15

Journal of Immunology
AllergyImmunology
2002English

Emperipolesis Mediated by CD8+ T Cells Correlates With Biliary Epithelia Cell Injury in Primary Biliary Cholangitis

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy